Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinovac Biotech : Indonesia discussing 90 mln to 100 mln COVID-19 vaccine doses from China

04/08/2021 | 03:03am EDT

JAKARTA, April 8 (Reuters) - Indonesia has been discussing with China the possibility of it supplying 90 million to 100 million doses of COVID-19 vaccines to plug its vaccine supply gaps, the Southeast Asian country's health minister said on Thursday.

Indonesia is concerned that delays in vaccine deliveries might disrupt its mass vaccination programme. The country relies heavily on vaccines made by China's Sinovac Biotech. (Reporting by Nilufar Rizki; Writing by Stanley Widianto; Editing by Martin Petty)


© Reuters 2021
All news about SINOVAC BIOTECH LTD.
04/16MARKET CHATTER : Sinovac Biotech's COVID-19 Vaccine 67% Effective in Chilean Stu..
MT
04/14SINOVAC BIOTECH  : Messi gifts Barca shirts to Sinovac Biotech for vaccines sent..
AQ
04/12Coronavirus pandemic 'a long way from over', WHO's Tedros says
RE
04/12SINOVAC BIOTECH  : Hong Kong plans to relax some COVID-19 rules for fully vaccin..
RE
04/11China considers mixing COVID-19 vaccines to boost protection rate
RE
04/11China considering mixing COVID-19 vaccines due to low efficacy rates
RE
04/10SINOVAC BIOTECH  : China's COVID-19 vaccine output to hit 3 billion by year-end ..
RE
04/10Sinopharm's protein-based COVID-19 vaccine candidate gets China clinical tria..
RE
04/08SINOVAC BIOTECH  : Indonesia discussing 90 mln to 100 mln COVID-19 vaccine doses..
RE
04/06SINOVAC BIOTECH  : WHO does not back vaccination passports for now - spokeswoman
RE
More news
Financials (USD)
Sales 2019 246 M - -
Net income 2019 44,9 M - -
Net cash 2019 183 M - -
P/E ratio 2019 17,8x
Yield 2019 -
Capitalization 640 M 640 M -
EV / Sales 2018 1,38x
EV / Sales 2019 1,86x
Nbr of Employees 910
Free-Float 45,6%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang Chief Financial Officer & Vice President
Qiang Gao Vice President-Research & Development
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SINOVAC BIOTECH LTD.0.00%640
CSL LIMITED-4.98%94 687
WUXI BIOLOGICS (CAYMAN) INC.2.14%56 894
SAMSUNG BIOLOGICS CO.,LTD.0.61%49 298
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.18.65%43 060
BIOGEN INC.10.45%40 696